Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic Patients. Diabetes, 2009;58(10):2267-2276). For ...
2009 NOV 23 ... histological evidence of injury, and markers of inflammatory activity. We used HapMap cell lines to find SNPs that tag for CD39 expression, and then compared the frequency of ... information, contact S.C. Robson, Harvard University, Beth Israel Deaconess Med Center, Transplantation Center, 330 Brookline Avenue, Boston, MA 02215, USA. Publisher contact ...
2009 NOV 23 ... in a Phase III trial of maintenance therapy +/-thalidomide after autologous stem cell transplantation. TCR Vbeta repertoire analysis identified T cell expansions in 48% of patients ...
2009 NOV 23 ... blood are presented in the report 'Late infectious complications after cord blood stem cell transplantation.' According to a study from the United States, "The slower engraftment kinetics and ...
2009 NOV 23 ... from patients undergoing heart transplantation. Patch-clamp experiments in whole-cell. configuration were performed to evaluate the effect of dihydrotestosterone on cardiac ...
2009 NOV 23 ... aspergillosis is a significant cause of morbidity and mortality in patients after stem cell transplantation, in solid organ transplant recipients, and in patients with hematological malignancies. ...
2009 NOV 23 ... "Type 2 diabetes (T2D) is characterized by reduction of beta-cell mass and dysfunctional insulin secretion. Understanding beta-cell phenotype changes as ... G.C. Weir, Harvard University, School Medical, Joslin Diabetes Center, Sect Islet Transplantation & Cell Biology, 1 Joslin Pl, Boston, MA 02215, USA. The publisher of the ...
2009 NOV 23 ... including the appropriate sequence of chemotherapy, combined modality therapy, and stem cell transplantation is not well-established," wrote H. Kohrt and colleagues, Stanford University, ...
2009 NOV 24 ... have the potential to transform into other phenotypes. In this study, we transplanted cell pellets of Meckel's chondrocytes into isogenic mouse spleens and analyzed their ... and immunohistochemical methods." "With the increasing duration of transplantation, chondrocytes were incorporated into splenic tissues and formed a von Kossa-positive ...
2009 NOV 28 ... by the body's inability to produce specific lysosomal enzymes. Lysosomes, part of a cell's internal machinery, help the body's cells break down large molecules and recycle ... experiments to reprogram the stem cells to produce IDUA. They then performed bone marrow transplantation on the MPS I mice with the reprogrammed cells. The developing red blood cells in these ...
Subject: Cincinnati Children's Hospital Medical Center
2009 NOV 23 ... (CR) could be shown only after introduction of high-dose therapy plus autologous stem cell transplantation (ASCT). In the context of ASCT, achieving CR (negative immunofixation and normal bone ...
2009 NOV 23 ... high rates following high-dose conventional cytotoxic therapy and autologous bone marrow cell (BMC) reconstitution. This study presents a series of transplant experiments aiming to ... a series of transplant experiments aiming to evaluate the efficacy of allogeneic BMC transplantation," scientists writing in the journal Cancer Immunology Immunotherapy report. ...
2009 NOV 23 ... from Heidelberg, Germany, "During acute rejection of cardiac transplants endothelial cell-leukocyte interaction fuelled by co-stimulatory molecules like CD40/CD154 may ultimately ... STAT-1 may protect the graft. To verify this hypothesis, heterotopic mouse heart transplantation was performed in the allogeneic B10.A(2R) to C57BL/6 and syngeneic C57BL/6 to C57BL/6 ...
2009 NOV 27 ... recognized as promising sources, which will spur ongoing efforts to evaluate these new cell sources for cell replacement therapy," wrote D.G. Wei and colleagues, University of ... and differentiation of endogenous cells at the damaged site and the autologous transplantation Recent findings Self-repair refers to a favorable structural and functional outcome of ...
2009 NOV 29 ... Morales said..The Thoratec HeartMate II, about the size of two "D" cell batteries laid end-to-end, received U. S. Food and Drug Administration approval on April ... the wait for a donor heart," said Dr. Jeffrey Dreyer, medical director of cardiac transplantation at Texas Children's Hospital.According to Morales, De Santiago is able to ...
2009 NOV 23 ... awaiting transplant. The Thoratec HeartMate II, about the size of two "D" cell batteries laid end-to-end, received U.S. Food and Drug Administration approval on April ... the wait for a donor heart," said Dr. Jeffrey Dreyer, medical director of cardiac transplantation at Texas Children's Hospital. According to Morales, De Santiago is able to ...
2009 NOV 23 ... worldwide. In fact, in the U.S., more people have PKD than cystic fibrosis, sickle cell anemia, hemophilia, muscular dystrophy, Down's syndrome and Huntington's Disease - ... the kidneys, which eventually cause kidney failure. At present there is no cure for PKD; transplantation and dialysis are the only treatments. The PKD Foundation is a global ...
